Metropolitan Life Insurance Company (MetLife)’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,901
| Closed | -$26.7K | – | 2344 |
|
|
2023
Q3 | $26.7K | Buy |
3,901
+345
| +10% | +$2.36K | ﹤0.01% | 1750 |
|
|
2023
Q2 | $36.9K | Buy |
3,556
+722
| +25% | +$7.49K | ﹤0.01% | 1608 |
|
|
2023
Q1 | $22.9K | Sell |
2,834
-1,540
| -35% | -$12.5K | ﹤0.01% | 1816 |
|
|
2022
Q4 | $68.9K | Buy |
4,374
+745
| +21% | +$11.7K | ﹤0.01% | 1279 |
|
|
2022
Q3 | $57.1K | Hold |
3,629
| – | – | ﹤0.01% | 1368 |
|
|
2022
Q2 | $50.7K | Buy |
3,629
+633
| +21% | +$8.84K | ﹤0.01% | 1499 |
|
|
2022
Q1 | $51.7K | Sell |
2,996
-9,700
| -76% | -$167K | ﹤0.01% | 1571 |
|
|
2021
Q4 | $185K | Hold |
12,696
| – | – | ﹤0.01% | 2083 |
|
|
2021
Q3 | $229K | Hold |
12,696
| – | – | ﹤0.01% | 1972 |
|
|
2021
Q2 | $223K | Buy |
+12,696
| New | +$223K | ﹤0.01% | 2066 |
|
|
2019
Q1 | – | Sell |
-12,078
| Closed | -$89.3K | – | 2550 |
|
|
2018
Q4 | $89.3K | Buy |
12,078
+1,022
| +9% | +$7.55K | ﹤0.01% | 2337 |
|
|
2018
Q3 | $161K | Hold |
11,056
| – | – | ﹤0.01% | 2156 |
|
|
2018
Q2 | $221K | Buy |
11,056
+3,589
| +48% | +$71.7K | ﹤0.01% | 1885 |
|
|
2018
Q1 | $131K | Hold |
7,467
| – | – | ﹤0.01% | 2154 |
|
|
2017
Q4 | $184K | Sell |
7,467
-6,907
| -48% | -$170K | ﹤0.01% | 1960 |
|
|
2017
Q3 | $371K | Hold |
14,374
| – | – | ﹤0.01% | 1881 |
|
|
2017
Q2 | $390K | Buy |
14,374
+6,313
| +78% | +$171K | ﹤0.01% | 1879 |
|
|
2017
Q1 | $240K | Hold |
8,061
| – | – | ﹤0.01% | 2153 |
|
|
2016
Q4 | $219K | Hold |
8,061
| – | – | ﹤0.01% | 2301 |
|
|
2016
Q3 | $206K | Buy |
+8,061
| New | +$206K | ﹤0.01% | 2319 |
|